Small agarose microcapsules with cell-enclosing hollow core for cell therapy: Transplantation of ifosfamide-activating cells to the mice with preestablished subcutaneous tumor

Cell Transplantation

Volumn 18, Issue 8, 2009, Pages 933-939

  Sakai, Shinji ^a   Hashimoto, Ichiro ^a   Tanaka, Shinji ^b   Salmons, Brian ^c   Kawakami, Koei ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Austrianova Singapore Pte Ltd   (Singapore)

Author keywords

Cell therapy; Cytochrome P450; Hollow core agarose microcapsule; Ifosfamide; Local therapy

Indexed keywords

AGAROSE; CYTOCHROME P450 2B1; IFOSFAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENGINEERING; CANCER INHIBITION; CELL ENCAPSULATION; CELL GROWTH; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; MICROCAPSULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; THICKNESS; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CAPSULES; CELL TRANSPLANTATION; CELLS, CULTURED; COMBINED MODALITY THERAPY; CYTOCHROME P-450 CYP2B1; DRUG DELIVERY SYSTEMS; IFOSFAMIDE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; SEPHAROSE; SKIN NEOPLASMS; TISSUE THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 72049105051     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X471143     Document Type: Article

References (27)

1. Bohman, S.; Waern, I.; Andersson, A.; King, A. Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets. Cell Transplant. 16:15-22; 2007. (Pubitemid 46516654)
2. Borlongan, C. V.; Thanos, C. G.; Skinner, S. J.; Geaney, M.; Emerich, D. F. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transplant. 16:987-992; 2007.
3. Chang, T. M. S. Semipermeable microcapsules. Science 146:524-525; 1964.
4. Chang, T. M. S.; Prakash, S. Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today 4:221-227; 1998.
5. Curcio, E.; Salerno, S.; Barbieri, G.; De Bartolo, L.; Drioli, E.; Bader, A. Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. Biomaterials 28:5487-5497; 2007. (Pubitemid 47599638)
6. de Vos, P.; Van Straaten, J. F. M.; Nieuwenhuizen, A. G.; de Groot, M.; Ploeg, R. J.; De Haan, P. J.; Van Schilfgaarde, R. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48:1381-1388; 1999.
7. Dirven, H. A.; Megens, L.; Oudshoorn, M. J.; Dingemanse, M. A.; van Ommen, B.; van Bladeren, P. J. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases. Chem. Res. Toxicol. 8:979-986; 1995.
8. Hassea, C.; Klöckb, G.; Schlosserb, A.; Zimmermannb, A.; Rothmundb, M. Parathyroid allotransplantation without immunosuppression. Lancet 350:1296-1297; 1997.
9. Hauser, O.; Prieschl Grassauer, E.; Salmons, B. Encapsulated, genetically modified cells producing in vivo therapeutics. Curr. Opin. Mol. Ther. 6:412-420; 2004.
10. Helmlinger, G.; Netti, P. A.; Lichtenbeld, H. C.; Melder, R. J.; Jain, R. K. Solid stress inhibits the growth of multicellular tumor spheroids. Nat. Biotechnol. 15:778-783; 1997.
11. Iwata, H.; Simada, H.; Fukuma, E.; Ibii, T.; Sato, H. Bioartificial pancreas research in Japan. Artif. Organs 28:45-52; 2004.
12. Kobayashi, T.; Aomatsu, Y.; Iwata, H.; Kin, T.; Kanehiro, H.; Hisanga, M.; Ko, S.; Nagao, M.; Harb, G.; Nakajima, Y. Survival of microencapsulated islets at 400 days post-transplantation in the omental pouch of NOD mice. Cell Transplant. 15:359-365; 2006. (Pubitemid 44162648)
13. Lin, R. Z.; Chang, H. Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol. J. 3:1172-1184; 2008.
14. Löhr, M.; Hoffmeyer, A.; Kröger, J.; Freund, M.; Hain, J.; Holle, A.; Karle, P.; Knöfel, W. T.; Liebe, S.; Müller, P.; Nizze, H.; Renner, M.; Saller, R. M.; Wagner, T.; Hauenstein, K.; Günzburg, W. H.; Salmons, B. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 357:1591-1592; 2001. (Pubitemid 32488821)
15. Löhr, M.; Kröger, J. C.; Hoffmeyer, A.; Freund, M.; Hain, J.; Holle, A.; Knöfel, W. T.; Liebe, S.; Nizze, H.; Renner, M.; Saller, R.; Karle, P.; Müller, P.; Wagner, T.; Hauenstein, K.; Salmons, B.; Günzburg, W. H. Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial. Cancer Ther. 1:121-131; 2003.
16. Löhr, M.; Müller, P.; Karle, P.; Stange, J.; Mitzner, S.; Jesnowski, R.; Nizze, H.; Nebe, B.; Liebe, S.; Salmons, B.; Günzburg, W. H. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Ther. 5:1070-1078; 1998.
17. Orive, G.; Hernandez, R. M.; Gascon, A. R.; Igartua, M.; Pedraz, J. L. Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 18:23-30; 2003.
18. Rihova, B. Immunocompatibility and biocompatibility of cell delivery systems. Adv. Drug Deliv. Rev. 42:65-80; 2000.
19. Robitaille, R.; Pariseau, J. F.; Leblong, F. A.; Lamoureux, M.; Lepage, Y.; Halle, J. P. Studies on small (<350 μm) alginate-poly-L-lysine microcapsules. III. Biocompatibility of smaller versus standard microcapsules. J. Biomed. Mater. Res. 44:116-120; 1999.
20. Sakai, S.; Hashimoto, I.; Kawakami, K. Agarose-gelatin conjugate membrane enhances proliferation of adherent cells enclosed in hollow-core microcapsules. J. Biomater. Sci. Polym. Edt. 19:937-944; 2008.
21. Sakai, S.; Hashimoto, I.; Kawakami, K. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules. Biotechnol. Bioeng. 99:235-243; 2008.
22. Sakai, S.; Kawabata, K.; Ono, T.; Ijima, H.; Kawakami, K. Development of mammalian cell-enclosing subsieve-size agarose capsules (<100 μm) for cell therapy. Biomaterials 26:4786-4792; 2005. (Pubitemid 40343027)
23. Sakai, S.; Kawabata, K.; Tanaka, S.; Harimoto, N.; Hashimoto, I.; Mu, C.; Salmons, B.; Ijima, H.; Kawakami, K. Subsieve-size agarose capsules enclosing ifosfamide-activating cells: A strategy toward chemotherapeutic targeting to tumors. Mol. Cancer Ther. 4:1786-1790; 2005.
24. Sakai, S.; Kawakami, K. Synthesis and characterization of both ionically and enzymatically crosslinkable alginate. Acta Biomater. 3:495-501; 2007.
25. Sakai, S.; Mu, C.; Kawabata, K.; Hashimoto, I.; Kawakami, K. Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. J. Biomed. Mater. Res. 78A:394-398; 2006.
26. Soon-Shiong, P. Treatment of type I diabetes using encapsulated islets. Adv. Drug Deliv. Rev. 35:259-270; 1999.
27. Uludag, H.; de Vos, P.; Tresco, P. A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42:29-64; 2000.